NCT06796127

Brief Summary

This study addresses congenital heart disease in fetuses, a specific birth defect, by collaborating with multicenter medical institutions across China. It prospectively collects echocardiographic screening, diagnostic images, and structured parameter data from both normal and abnormal fetuses. Cases are followed up, and artificial intelligence (AI) models are developed to extract fetal heart echocardiographic image features and analyze the data. This process allows for the analysis of the AI models' accuracy, sensitivity, and specificity, and verifies the application value of AI models in fetal heart echocardiographic screening and diagnosis.

Trial Health

63
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
10,000

participants targeted

Target at P75+ for all trials

Timeline
1mo left

Started Feb 2025

Geographic Reach
1 country

1 active site

Status
not yet recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress91%
Feb 2025Aug 2026

First Submitted

Initial submission to the registry

January 20, 2025

Completed
8 days until next milestone

First Posted

Study publicly available on registry

January 28, 2025

Completed
4 days until next milestone

Study Start

First participant enrolled

February 1, 2025

Completed
1 year until next milestone

Primary Completion

Last participant's last visit for primary outcome

February 1, 2026

Completed
6 months until next milestone

Study Completion

Last participant's last visit for all outcomes

August 1, 2026

Expected
Last Updated

January 28, 2025

Status Verified

January 1, 2025

Enrollment Period

1 year

First QC Date

January 20, 2025

Last Update Submit

January 26, 2025

Conditions

Outcome Measures

Primary Outcomes (1)

  • Diagnostic efficiency of AI model for fetal CHD

    From enrollment to diagnostic verification, the evaluation period should not exceed 12 month.

Eligibility Criteria

Sexfemale
Healthy VolunteersYes
Age GroupsChild (0-17), Adult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

The study population was from 20 multi-center medical institutions in China, and pregnant women who underwent fetal echocardiography between 16 and 40 weeks of gestation.

You may qualify if:

  • Single or multiple pregnancy;
  • Gestational age 16-40 weeks;
  • Fetal echocardiographic images are clear and complete;
  • Clinical data are complete and detailed;
  • Sign informed consent and be able to cooperate with follow-up

You may not qualify if:

  • Fetal echocardiographic images are incomplete or of poor quality that cannot be used for research;
  • Refusal or loss of follow-up

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Beijing Anzhen Hospital affiliated to Capital Medical University

Beijing, Beijing Municipality, 100010, China

Location

MeSH Terms

Conditions

Heart Defects, Congenital

Condition Hierarchy (Ancestors)

Cardiovascular AbnormalitiesCardiovascular DiseasesHeart DiseasesCongenital AbnormalitiesCongenital, Hereditary, and Neonatal Diseases and Abnormalities

Study Design

Study Type
observational
Observational Model
OTHER
Time Perspective
PROSPECTIVE
Target Duration
1 Year
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

January 20, 2025

First Posted

January 28, 2025

Study Start

February 1, 2025

Primary Completion

February 1, 2026

Study Completion (Estimated)

August 1, 2026

Last Updated

January 28, 2025

Record last verified: 2025-01

Data Sharing

IPD Sharing
Will share
Shared Documents
STUDY PROTOCOL

Locations